Research Article

Lysophosphatidic Acid Analogue rather than Lysophosphatidic Acid Promoted the Bone Formation In Vivo

Table 2

The hepatic and renal functions of mice after treatment with LPA or analogues were determined by blood chemistry tests.

IndexControlLPAAnalogues

TP (g/L)35.97 ± 0.2536.10 ± 1.1735.73 ± 1.43
ALB (g/L)27.00 ± 2.2726.80 ± 0.9626.77 ± 0.74
GLOB (g/L)9.06 ± 1.559.01 ± 1.229.17 ± 0.86
A/G3.09 ± 0.513.03 ± 0.382.95 ± 0.29
ALT (U/L)55.00 ± 3.7453.33 ± 3.5751.67 ± 5.78
ALP (U/L)5.07 ± 2.125.17 ± 0.175.05 ± 0.13
AST (U/L)104.73 ± 6.70100.43 ± 3.63103.33 ± 9.57
BUN (mmol/L)6.58 ± 0.056.50 ± 0.096.44 ± 0.12
CRE (μmol/L)39.13 ± 2.1237.80 ± 1.6137.77 ± 3.07

TP: total protein; ALB: albumin; GLOB: globulin; A/G: albumin/globulin ratio; ALT: alanine aminotransferase; AST: aspartate aminotransferase; ALP: alkaline phosphatase; BUN: blood urea nitrogen; CRE: creatinine.